학술논문
Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: Outcome and Minimal Residual Disease (MRD) from the Full Population of the Pivotal M13-982 Trial
Document Type
Abstract
Author
Wierda, William; Chyla, Brenda; Eichhorst, Barbara; Schetelig, Johannes; Munir, Talha; Hillmen, Peter; Seymour, John F.; Roberts, Andrew W.; Coutre, Steven; Jurczak, Wojciech; Mulligan, Stephen P.; Wendtner, Clemens-Martin; Davids, Matthew; Böettcher, Sebastian; Cerri, Elisa; Zhou, Lang; Popovic, Relja; Poteracki, Mia; Arzt, Jennifer; Kim, Su Young; Verdugo, Maria; Bhathena, Anahita; Stilgenbauer, Stephan; Hallek, Michael
Source
In Clinical Lymphoma Myeloma and Leukemia September 2017 17 Supplement 2:S303-S303
Subject
Language
ISSN
2152-2650